Ajooni Biotech Limited (NSE:AJOONI)
4.630
+0.380 (8.94%)
Mar 6, 2026, 3:29 PM IST
Ajooni Biotech Revenue
Ajooni Biotech had revenue of 587.53M INR in the quarter ending December 31, 2025, with 72.63% growth. This brings the company's revenue in the last twelve months to 1.52B, up 44.77% year-over-year. In the fiscal year ending March 31, 2025, Ajooni Biotech had annual revenue of 1.16B with 44.38% growth.
Revenue (ttm)
1.52B
Revenue Growth
+44.77%
P/S Ratio
0.53
Revenue / Employee
11.36M
Employees
134
Market Cap
800.93M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.16B | 356.18M | 44.38% |
| Mar 31, 2024 | 802.54M | 57.66M | 7.74% |
| Mar 31, 2023 | 744.88M | 4.50M | 0.61% |
| Mar 31, 2022 | 740.38M | 229.99M | 45.06% |
| Mar 31, 2021 | 510.39M | 110.06M | 27.49% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Gokul Refoils & Solvent | 39.25B |
| Mukka Proteins | 14.50B |
| Sarveshwar Foods | 13.13B |
| McLeod Russel India | 11.89B |
| Regaal Resources | 11.48B |
| Dhunseri Tea & Industries | 4.96B |
| Future Consumer | 4.50B |
| M. K. Proteins | 3.74B |
Ajooni Biotech News
- 1 year ago - Ajooni Biotech secures BIS certification for mineral mixture product - Business Upturn